Eli Lilly And Company Ltd v Human Genome Sciences Inc: ECJ 12 Dec 2013

ECJ Medicinal products for human use – Supplementary protection certificate – Regulation (EC) No 469/2009 – Article 3 – Conditions for obtaining such a certificate – Concept of a ‘product protected by a basic patent in force’ – Criteria – Wording of the claims of the basic patent – Precision and specificity – Functional definition of an active ingredient – Structural definition of an active ingredient – European Patent Convention

Citations:

C-493/12, [2013] EUECJ C-493/12

Links:

Bailii

Statutes:

Regulation (EC) No 469/2009 3

Jurisdiction:

European

Licensing

Updated: 11 August 2022; Ref: scu.518962